🇪🇺 Hu1124 in European Union

EMA authorised Hu1124 on 20 September 2004

Marketing authorisation

EMA — authorised 20 September 2004

  • Status: approved

Hu1124 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is Hu1124 approved in European Union?

Yes. EMA authorised it on 20 September 2004.

Who is the marketing authorisation holder for Hu1124 in European Union?

Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.